BIOCRAFT GENERIC CEPHALEXIN ANTIDUMPING SUIT VERSUS LYPHOMED WILL BE HEARD BY ITC ON DEC. 7; COMMERCE ANNOUNCES INTENT TO INVESTIGATE PENDING ITC DECISION

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".